In the BioHarmony Drug Report Database

"Preview" Icon

Ramipril

Altace (ramipril) is a small molecule pharmaceutical. Ramipril was first approved as Altace on 1991-01-28. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against angiotensin-converting enzyme.

 

Trade Name

 

Altace
 

Common Name

 

ramipril
 

ChEMBL ID

 

CHEMBL1168
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Ramipril structure rendering